Advances in Topical Hemostatic Agent Therapies: A Comprehensive Update.


Journal

Advances in therapy
ISSN: 1865-8652
Titre abrégé: Adv Ther
Pays: United States
ID NLM: 8611864

Informations de publication

Date de publication:
10 2020
Historique:
received: 09 07 2020
pubmed: 20 8 2020
medline: 15 4 2021
entrez: 20 8 2020
Statut: ppublish

Résumé

Severe hemorrhage causes significant metabolic and cellular dysfunction secondary to deficient tissue perfusion and oxygen delivery. If bleeding continues, hemodynamic destabilization, hypoxemia, multiple organ failure, and death will occur. Techniques employed to promote hemostasis include surgical suture ligatures, cautery, chemical agents, self-assembling nanoparticles, and physical methods, like mechanical pressure. Improved understanding of the natural clotting cascade has allowed newly designed agents to become more targeted for clinical and military use. Topically-applied hemostatic agents have enormous clinical applications in achieving hemostasis. This manuscript describes currently available and developing topical hemostatic materials, including topical active agents, mechanical agents, synthetic/hemisynthetic hemostatic agents, and external hemostatic dressings for clinical practice.

Identifiants

pubmed: 32813165
doi: 10.1007/s12325-020-01467-y
pii: 10.1007/s12325-020-01467-y
doi:

Substances chimiques

Fibrin Tissue Adhesive 0
Hemostatics 0

Types de publication

Journal Article Review

Langues

eng

Pagination

4132-4148

Auteurs

Liang Huang (L)

Department of Anesthesiology, Perioperative and Pain Medicine, New York University Langone School of Medicine, New York, USA.

Geoffrey L Liu (GL)

Department of Radiology, Ochsner Clinic Foundation, New Orleans, LA, USA.

Alan D Kaye (AD)

Department of Anesthesiology and Pharmacology, LSU Health Shreveport, Shreveport, LA, USA.
Department of Toxicology, and Neurosciences, LSU Health Shreveport, Shreveport, LA, USA.

Henry Liu (H)

Department of Anesthesiology and Perioperative Medicine, Milton S. Hershey Medical Center, Penn State University School of Medicine, Hershey, PA, USA. henryliupa@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH